glp 1 depression anxiety Alleviation of by Glucagon-Like Peptide Through the Regulation of Neuroinflammation, Neurotransmitters, Neurogenesis, and Synaptic Function Cumulative incidence of depression and
Description
Then it happens again, and you start to wonder if something actually changed
Similar to REMODEL, the SMART trial (NCT04889183), completed in 2024, explored mechanisms of human kidney protection by 2.4 mg subcutaneous semaglutide in 125 overweight/obese participants with A2A3 albuminuria without T2DM, with a primary endpoint of albuminuria
Publisher | Google Scholor Singh K, Aulakh SK, Nijjar GS, Singh S, Sandhu APS, et al
While reassuring, the authors also touched on the rapidly evolving nature of GLP-1 science

While does Wegovy cause kidney stones is a common concern, there is currently no established direct causal link between semaglutide and kidney stone formation
DPP-4 inhibitors-renoprotection in diabetic nephropathy
